We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Akoya Biosciences Inc (AKYA) USD0.00001

Sell:$9.92 Buy:$10.01 Change: $0.23 (2.25%)
Market closed |  Prices as at close on 27 January 2022 | Switch to live prices |
Change: $0.23 (2.25%)
Market closed |  Prices as at close on 27 January 2022 | Switch to live prices |
Change: $0.23 (2.25%)
Market closed |  Prices as at close on 27 January 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Akoya Biosciences, Inc. is a life sciences technology company. The Company provides spatial biology solutions. Through its Co-Detection by indEXing (CODEX) and Phenoptics platforms, reagents, software and services, it offers end-to-end solutions to perform tissue analysis and spatial phenotyping across the continuum, from discovery through translational and clinical research. CODEX is a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition. It provides a comprehensive spatial biology solution, converting its customer’s standard fluorescent microscope into an automated imaging system to produce ultra-high parameter multiplex images capable of providing in situ analysis at the cellular and subcellular scales. Its Phenoptics platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or FFPE tissue sections and tissue microarrays (TMAs) utilizing an automated and high-throughput workflow.

Contact details

100 Campus Drive, 6Th Floor
United States
+1 (415) 7656980

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$380.26 million
Shares in issue:
37.21 million
Life Sciences Tools & Services
United States
US dollar
NASDAQ Comb. Composite

Key personnel

  • Brian McKelligon
    President, Chief Executive Officer, Director
  • Joseph Driscoll
    Chief Financial Officer
  • Frederic Pla
    Chief Operating Officer
  • Marilee Moy
    Chief People Officer
  • Pascal Bamford
    Senior Vice President - Research and Development and Laboratory Operations
  • Seth Benson
    Vice President - Business Operations
  • Peter Miller
    Vice President - Research & Development, Phenoptics
  • Niro Ramachandran
    Chief Business Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.